Table 4.

Antibiotic treatment and the risk of CSA-AKI in high NLPR groups (n = 365).

Antibiotic use	Total		NLPR (2.00–2.99)		NLPR (≥3.00)
	AKI	aOR	AKI	aOR	AKI	aOR
	(%)	(95% CI)a	(%)	(95% CI)a	(%)	(95% CI)a
Yes	27	0.44	10	0.39	17	0.44
	(32.9)	(0.26–0.76)	(29.4)	(0.16–0.95)	(35.4)	(0.21–0.91)
No	155	Ref	85	Ref	70	Ref
	(54.8)		(51.2)		(59.8)

^aOR was adjusted by age, gender, and body mass index.

AKI: acute kidney injury; aOR: adjusted odds ratio; NLPR: neutrophil to platelet*lymphocyte ratio.